 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
1ttu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
regulation of transcription, DNA-dependent
|
1 term
|
 |
|
Biochemical function
|
protein binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
23:3441-3451
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA.
|
|
R.A.Kovall,
W.A.Hendrickson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Notch signaling is a conserved pathway of communication between neighboring
cells that results in cell fate specification, and CSL is the universal
transcriptional effector of Notch signaling. The Notch intracellular domain
translocates to the nucleus after proteolytic release upon Notch extracellular
engagement, and there it displaces corepressors from DNA-bound CSL and recruits
activators of Notch target genes. Here we report the 2.85 A crystal structure of
CSL with a target DNA. CSL comprises three structurally integrated domains: its
amino (NTD)- and carboxy (CTD)-terminal domains are strikingly similar to those
of Rel transcription factors, but a surprising beta-trefoil domain (BTD) is
inserted between them. CSL-bound DNA is recognized specifically by conserved
residues from NTD and BTD. A hydrophobic pocket on BTD is identified as the
likely site of Notch interaction with CSL, which has functional implications for
the mechanism of Notch signaling.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4 Arrangement of CTD and RHR-C with respect to NTD and
RHR-N. The orientation of CTD and RHR-C in relation to NTD and
RHR-N and DNA were compared for CSL and Rel proteins. The
NFAT/Fos-Jun/DNA (1A02) structure is depicted on the left, the
p52 homodimer -DNA structure (1A3Q) is displayed on the right,
and the CSL -DNA structure is in the middle. In each case, RHR-N
or NTD is colored blue and RHR-C or CTD is orange. For the
comparison, the NFAT and p52 RHR-N domains were overlaid with
the NTD of CSL. The p52 protomer that is not used for the
overlay is lightly shaded. The orientation of RHR-N and NTD with
respect to the DNA is similar in all cases; however, the
resulting orientation of the RHR-C domain is different in all
three examples, and unlike the RHR-C domains of NFAT and p52,
the CSL CTD does not contact DNA, nor is it involved in any
protein -protein interactions that promote dimerization. The
figure was created with Molscript and Povscript (Kraulis, 1991;
Fenn et al, 2003).
|
 |
Figure 7.
Figure 7 CSL -DNA interactions. (B -D) were created with
Molscript and Povscript (Kraulis, 1991; Fenn et al, 2003). (A)
Schematic representation of all protein -DNA interactions in the
CSL -DNA complex. Specific interactions with the DNA bases are
shaded in gray and nonspecific interactions are clear boxes.
Hydrogen-bonding or salt-bridge interactions are denoted as an
arrow and Van der Waals interactions are depicted as closed
circles. (B) Stereo view of the major-groove protein -DNA
interactions of Arg234 and Asn26 from CSL with Gua8 and Gua9.
The DNA is colored atom-specifically: C yellow, N blue, O red,
and P gray. The protein is colored blue with interacting loops
solid and other parts transparent. (C) Stereo view of the
interaction of Lys368 with Gua10 and Thy7'. Coloring is as in
(B). (D) Stereo view of the minor-groove interactions of the
side chain of Gln401 with Ade13' and the backbone carbonyl of
Ser400 with Gua6. Coloring is as in (B).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2004,
23,
3441-3451)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.Calderwood,
S.Lee,
A.M.Holthaus,
S.C.Blacklow,
E.Kieff,
and
E.Johannsen
(2011).
Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
|
| |
Virology, 414,
19-25.
|
 |
|
|
|
|
 |
D.R.Friedmann,
and
R.A.Kovall
(2010).
Thermodynamic and structural insights into CSL-DNA complexes.
|
| |
Protein Sci, 19,
34-46.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Y.Wang,
F.S.Fuda,
W.Chen,
and
N.J.Karandikar
(2010).
Notch1 in primary effusion lymphoma: a clinicopathological study.
|
| |
Mod Pathol, 23,
773-780.
|
 |
|
|
|
|
 |
K.L.Arnett,
M.Hass,
D.G.McArthur,
M.X.Ilagan,
J.C.Aster,
R.Kopan,
and
S.C.Blacklow
(2010).
Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes.
|
| |
Nat Struct Mol Biol, 17,
1312-1317.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Y.Kim,
E.J.Ann,
J.S.Mo,
F.Dajas-Bailador,
M.S.Seo,
J.A.Hong,
J.Jung,
Y.H.Choi,
J.H.Yoon,
S.M.Kim,
E.J.Choi,
H.S.Hoe,
A.J.Whitmarsh,
and
H.S.Park
(2010).
JIP1 binding to RBP-Jk mediates cross-talk between the Notch1 and JIP1-JNK signaling pathway.
|
| |
Cell Death Differ, 17,
1728-1738.
|
 |
|
|
|
|
 |
R.Rohs,
X.Jin,
S.M.West,
R.Joshi,
B.Honig,
and
R.S.Mann
(2010).
Origins of specificity in protein-DNA recognition.
|
| |
Annu Rev Biochem, 79,
233-269.
|
 |
|
|
|
|
 |
S.E.Johnson,
M.X.Ilagan,
R.Kopan,
and
D.Barrick
(2010).
Thermodynamic analysis of the CSL x Notch interaction: distribution of binding energy of the Notch RAM region to the CSL beta-trefoil domain and the mode of competition with the viral transactivator EBNA2.
|
| |
J Biol Chem, 285,
6681-6692.
|
 |
|
|
|
|
 |
S.Zanotti,
and
E.Canalis
(2010).
Notch and the skeleton.
|
| |
Mol Cell Biol, 30,
886-896.
|
 |
|
|
|
|
 |
E.Gazave,
P.Lapébie,
G.S.Richards,
F.Brunet,
A.V.Ereskovsky,
B.M.Degnan,
C.Borchiellini,
M.Vervoort,
and
E.Renard
(2009).
Origin and evolution of the Notch signalling pathway: an overview from eukaryotic genomes.
|
| |
BMC Evol Biol, 9,
249.
|
 |
|
|
|
|
 |
K.Karasawa,
N.Sakamoto,
K.Fujita,
H.Ochiai,
T.Fujii,
K.Akasaka,
and
T.Yamamoto
(2009).
Suppressor of Hairless (Su(H)) is required for foregut development in the sea urchin embryo.
|
| |
Zoolog Sci, 26,
686-690.
|
 |
|
|
|
|
 |
M.K.Hancock,
L.Kopp,
and
K.Bi
(2009).
High-throughput screening compatible cell-based assay for interrogating activated notch signaling.
|
| |
Assay Drug Dev Technol, 7,
68-79.
|
 |
|
|
|
|
 |
Y.Izumiya,
C.Izumiya,
D.Hsia,
T.J.Ellison,
P.A.Luciw,
and
H.J.Kung
(2009).
NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.
|
| |
J Virol, 83,
4435-4446.
|
 |
|
|
|
|
 |
C.Del Bianco,
J.C.Aster,
and
S.C.Blacklow
(2008).
Mutational and energetic studies of Notch 1 transcription complexes.
|
| |
J Mol Biol, 376,
131-140.
|
 |
|
|
|
|
 |
D.R.Friedmann,
J.J.Wilson,
and
R.A.Kovall
(2008).
RAM-induced allostery facilitates assembly of a notch pathway active transcription complex.
|
| |
J Biol Chem, 283,
14781-14791.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.A.Kovall
(2008).
More complicated than it looks: assembly of Notch pathway transcription complexes.
|
| |
Oncogene, 27,
5099-5109.
|
 |
|
|
|
|
 |
W.R.Gordon,
K.L.Arnett,
and
S.C.Blacklow
(2008).
The molecular logic of Notch signaling--a structural and biochemical perspective.
|
| |
J Cell Sci, 121,
3109-3119.
|
 |
|
|
|
|
 |
M.Prevorovský,
F.Půta,
and
P.Folk
(2007).
Fungal CSL transcription factors.
|
| |
BMC Genomics, 8,
233.
|
 |
|
|
|
|
 |
O.Y.Lubman,
M.X.Ilagan,
R.Kopan,
and
D.Barrick
(2007).
Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch.
|
| |
J Mol Biol, 365,
577-589.
|
 |
|
|
|
|
 |
R.A.Kovall
(2007).
Structures of CSL, Notch and Mastermind proteins: piecing together an active transcription complex.
|
| |
Curr Opin Struct Biol, 17,
117-127.
|
 |
|
|
|
|
 |
T.Kitamura,
Y.I.Kitamura,
Y.Funahashi,
C.J.Shawber,
D.H.Castrillon,
R.Kollipara,
R.A.DePinho,
J.Kitajewski,
and
D.Accili
(2007).
A Foxo/Notch pathway controls myogenic differentiation and fiber type specification.
|
| |
J Clin Invest, 117,
2477-2485.
|
 |
|
|
|
|
 |
T.Masui,
Q.Long,
T.M.Beres,
M.A.Magnuson,
and
R.J.MacDonald
(2007).
Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex.
|
| |
Genes Dev, 21,
2629-2643.
|
 |
|
|
|
|
 |
X.Ma,
M.J.Renda,
L.Wang,
E.C.Cheng,
C.Niu,
S.W.Morris,
A.S.Chi,
and
D.S.Krause
(2007).
Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation.
|
| |
Mol Cell Biol, 27,
3056-3064.
|
 |
|
|
|
|
 |
A.Klinakis,
M.Szabolcs,
K.Politi,
H.Kiaris,
S.Artavanis-Tsakonas,
and
A.Efstratiadis
(2006).
Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.
|
| |
Proc Natl Acad Sci U S A, 103,
9262-9267.
|
 |
|
|
|
|
 |
C.T.Ong,
H.T.Cheng,
L.W.Chang,
T.Ohtsuka,
R.Kageyama,
G.D.Stormo,
and
R.Kopan
(2006).
Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability.
|
| |
J Biol Chem, 281,
5106-5119.
|
 |
|
|
|
|
 |
D.Barrick,
and
R.Kopan
(2006).
The Notch transcription activation complex makes its move.
|
| |
Cell, 124,
883-885.
|
 |
|
|
|
|
 |
J.J.Wilson,
and
R.A.Kovall
(2006).
Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.
|
| |
Cell, 124,
985-996.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.D.Carroll,
W.Bu,
D.Palmeri,
S.Spadavecchia,
S.J.Lynch,
S.A.Marras,
S.Tyagi,
and
D.M.Lukac
(2006).
Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
|
| |
J Virol, 80,
9697-9709.
|
 |
|
|
|
|
 |
M.C.Cantarini,
S.M.de la Monte,
M.Pang,
M.Tong,
A.D'Errico,
F.Trevisani,
and
J.R.Wands
(2006).
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
|
| |
Hepatology, 44,
446-457.
|
 |
|
|
|
|
 |
S.J.Bray
(2006).
Notch signalling: a simple pathway becomes complex.
|
| |
Nat Rev Mol Cell Biol, 7,
678-689.
|
 |
|
|
|
|
 |
T.M.Beres,
T.Masui,
G.H.Swift,
L.Shi,
R.M.Henke,
and
R.J.MacDonald
(2006).
PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L.
|
| |
Mol Cell Biol, 26,
117-130.
|
 |
|
|
|
|
 |
Y.Nam,
P.Sliz,
L.Song,
J.C.Aster,
and
S.C.Blacklow
(2006).
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes.
|
| |
Cell, 124,
973-983.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.J.McKenzie,
M.Khan,
E.Briend,
Y.Stallwood,
and
B.R.Champion
(2005).
Notch: a unique therapeutic target for immunomodulation.
|
| |
Expert Opin Ther Targets, 9,
395-410.
|
 |
|
|
|
|
 |
S.E.Pursglove,
and
J.P.Mackay
(2005).
CSL: a notch above the rest.
|
| |
Int J Biochem Cell Biol, 37,
2472-2477.
|
 |
|
|
|
|
 |
X.Meng,
M.H.Brodsky,
and
S.A.Wolfe
(2005).
A bacterial one-hybrid system for determining the DNA-binding specificity of transcription factors.
|
| |
Nat Biotechnol, 23,
988-994.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|